Published in Circulation on August 01, 1975
Do coronary artery bypass operations prolong life? West J Med (1982) 0.97
Long term follow up after elective percutaneous coronary intervention for unprotected non-bifurcational left main stenosis: is it time to change the guidelines? Heart (2003) 0.91
Cardiac pain at rest. Management and follow-up of 100 consecutive cases. Br Heart J (1981) 0.87
Preoperative intra-aortic balloon support in surgery for left main coronary stenosis. Ann Surg (1977) 0.84
Optimal revascularization for complex coronary artery disease. Nat Rev Cardiol (2013) 0.83
Invasive assessment modalities of unprotected left main stenosis. J Saudi Heart Assoc (2014) 0.82
Further evaluation of the surgical treatment of obstructive disease of the left main coronary artery. Ann Surg (1978) 0.80
Exercise testing in men with significant left main coronary disease. Br Heart J (1979) 0.80
Percutaneous coronary artery stenting of unprotected left main coronary artery disease using drug-eluting stents: the initial Baylor University Medical Center experience. Proc (Bayl Univ Med Cent) (2007) 0.78
Unprotected left main coronary artery intervention for acute myocardial infarction and cardiogenic shock. Tex Heart Inst J (2007) 0.78
Safety and feasibility of coronary stenting in unprotected left main coronary artery disease in the real world clinical practice--a single center experience. PLoS One (2014) 0.77
"You don't need a weather man to know which way the wind blows": understanding differences and applications in clinical practice of randomized controlled trials on unprotected left main. Ann Transl Med (2017) 0.75
Isolated left coronary ostial stenosis--a case report. Korean J Intern Med (1990) 0.75
Survival with total occlusion of left main coronary artery. Tex Heart Inst J (1984) 0.75
Acute left main coronary artery occlusion. Pak J Med Sci (2013) 0.75
Predictors of operative mortality for coronary bypass grafting in patients with ischemic heart disease. Yale J Biol Med (1978) 0.75
Comparison of coronary artery bypass grafting with percutaneous coronary intervention for unprotected left main coronary artery disease. Yonsei Med J (2012) 0.75
Very long-term follow-up for left main coronary artery stenting: a missing piece of the jigsaw puzzle. J Thorac Dis (2016) 0.75
Bypass surgery for left main coronary artery disease. Reduced perioperative myocardial infarction with preoperative intra-aortic balloon counterpulsation. Br Heart J (1980) 0.75
UPDATE ON SURGERY FOR CORONARY ARTERY OCCLUSIVE DISEASE. Cardiovasc Dis (1979) 0.75
Study of Short and Intermediate Term Clinical Outcomes of Patients with Protected and Unprotected LMCA Stenting. J Clin Diagn Res (2017) 0.75
Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol (1976) 6.84
Clinical significance of coronary arterial ectasia. Am J Cardiol (1976) 3.43
Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res (2000) 3.19
Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol (1988) 3.10
Prospective correlative study of ventricular aneurysm. Mechanistic concept and clinical recognition. Am J Med (1967) 2.56
The anginal syndrome associated with normal coronary arteriograms. Report of a six year experience. Am J Med (1973) 2.50
Localized disorders in myocardial contraction. Asynergy and its role in congestive heart failure. N Engl J Med (1967) 2.47
Pharmacologic control of thromboembolic complications of cardiac-valve replacement. N Engl J Med (1971) 2.40
Propranolol and angina pectoris. Am J Cardiol (1966) 2.32
The nature and course of depression following myocardial infarction. Arch Intern Med (1989) 2.19
Air travel and thrombotic episodes: the economy class syndrome. Lancet (1988) 1.93
Myocardial revascularization with internal mammary artery implantation: current status. JAMA (1969) 1.84
Implications of left ventricular asynergy. Am J Cardiol (1969) 1.83
The anginal syndrome with normal coronary arteriography. Trans Assoc Am Physicians (1967) 1.81
A hemodynamic study of left ventricular aneurysm. Circulation (1967) 1.80
Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res (1995) 1.75
Cardiovascular pharmacology of propranolol in man. Circulation (1969) 1.69
Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol (1985) 1.68
Clinical presentation and non-invasive diagnosis of right heart masses. Br Heart J (1981) 1.67
Left ventricular ejection fraction as a prognostic guide in surgical treatment of coronary and valvular heart disease. Am J Cardiol (1974) 1.67
Modified orifice equation for the calculation of mitral valve area. Am Heart J (1972) 1.60
Abnormal mitral valve motion associated with ventricular septal defect following acute myocardial infarction. Am Heart J (1979) 1.59
Coronary heart disease. Clinical, cinearteriographic and metabolic correlations. Am J Cardiol (1966) 1.57
Physicians' reactions to patients. A key to teaching humanistic medicine. N Engl J Med (1983) 1.54
Functional importance of the human coronary collateral circulation. N Engl J Med (1971) 1.52
Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia. J Am Coll Cardiol (2001) 1.49
No confirmation for a causal role of volume-regulated chloride channels in ischemic preconditioning in rabbits. J Mol Cell Cardiol (2000) 1.49
Angiographic patterns of balloon inflation during percutaneous transluminal coronary angioplasty: role of pressure-diameter curves in studying distensibility and elasticity of the stenotic lesion and the mechanism of dilation. J Am Coll Cardiol (1990) 1.49
Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol (1985) 1.46
Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease. Am J Cardiol (1969) 1.45
The intermediate coronary syndrome: clinical, angiographic and therapeutic aspects. N Engl J Med (1973) 1.43
A generalized formulation of the Gorlin formula for calculating the area of the stenotic mitral valve and other stenotic cardiac valves. J Am Coll Cardiol (1990) 1.41
Isolated collapse of left-sided heart chambers in cardiac tamponade: demonstration by two-dimensional echocardiography. Am Heart J (1991) 1.40
Subaortic stenosis: a reviewed concept of the disease. 1959. Medicine (Baltimore) (1993) 1.39
Depression of myocardial contractility in rats by free fatty acids during hypoxia. Circ Res (1970) 1.38
Physiologic Evaluation of Patients with Mitral Stenosis before and After Mitral Valvuloplasty. Trans Am Clin Climatol Assoc (1950) 1.38
Signal transduction of ischemic preconditioning. Cardiovasc Res (2001) 1.38
Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report. N Engl J Med (1968) 1.38
Progression of coronary artery disease. A clinical arteriographic study. Circulation (1973) 1.37
Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol (1997) 1.36
Production of free radicals and lipid peroxides in early experimental myocardial ischemia. J Mol Cell Cardiol (1983) 1.36
Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Circulation (1979) 1.35
An electrocardiographic, anatomic, and metabolic study of zonal myocardial ischemia in coronary heart disease. Circulation (1967) 1.34
Mechanisms of angina in aortic stenosis. Circulation (1967) 1.34
Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol (1999) 1.33
Analysis of the p63 gene in classical EEC syndrome, related syndromes, and non-syndromic orofacial clefts. J Med Genet (2002) 1.33
Doppler echocardiographic analysis of left ventricular filling in treated hypertensive patients. J Am Coll Cardiol (1987) 1.30
Differential response of large and small coronary arteries to nitroglycerin and angiotensin. Autoregulation and tachyphylaxis. Circ Res (1973) 1.29
Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol (1994) 1.29
Detection and sizing of acute myocardial infarcts with 99mTc (Sn) tetracycline. N Engl J Med (1974) 1.28
Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology (1997) 1.26
Detection of residual myocardial function in coronary artery disease using post-extra systolic potentiation. Circulation (1974) 1.25
Angiographic evolution of coronary artery morphology in unstable angina. J Am Coll Cardiol (1986) 1.24
Coronary atherosclerosis, coronary collaterals, and their relation to cardiac function. Ann Intern Med (1970) 1.23
Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol (1997) 1.22
Dynamic geometry of the left ventricle in mitral regurgitation. Circulation (1973) 1.22
Acute myocardial infarction in a nineteen-year-old student in the absence of coronary obstructive disease. N Engl J Med (1970) 1.21
Ischemic preconditioning: from basic mechanisms to clinical applications. Pharmacol Ther (2000) 1.21
Indications for left ventricular aneurysmectomy. Circulation (1983) 1.20
Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol (1995) 1.18
Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol (1995) 1.17
Electrocardiographic, arteriographic and ventriculographic correlations in transmural myocardial infarction. Am J Cardiol (1973) 1.17
Ventriculographic patterns and hemodynamics in primary myocardial disease. Circulation (1973) 1.16
Selective revascularization of the myocardium by internal-mammary-artery implant. N Engl J Med (1966) 1.16
Septal perforator compression (narrowing) in idiopathic hypertrophic subaortic stenosis. Am J Cardiol (1977) 1.15
Prognosis in medically-treated coronary artery disease: influence of ejection fraction compared to other parameters. Circulation (1975) 1.14
Atrial pacing in coronary heart disease. Effect on hemodynamics, metabolism and coronary circulation. Am J Cardiol (1971) 1.14
Cellular mechanisms in ischemic preconditioning: the role of adenosine and protein kinase C. Ann N Y Acad Sci (1994) 1.13
Postextrasystolic potentiation as a predictor of potential myocardial viability: preoperative analyses compared with studies after coronary bypass surgery. Am J Cardiol (1977) 1.13
The coronary circulation, myocardial ischemia, and angina pectoris (II). Mod Concepts Cardiovasc Dis (1966) 1.13
Right ventricular performance in patients with coronary artery disease. Circulation (1975) 1.12
Platelet studies in patients with coronary artery disease and in their relatives. Br Heart J (1972) 1.12
Total occlusion of the left main coronary artery. A clinical, hemodynamic and angiographic profile. Am J Med (1978) 1.11
Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol (2000) 1.10
Study of left ventricular geometry and function by B-scan ultrasonography in patients with and without asynergy. N Engl J Med (1974) 1.09
Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction? Basic Res Cardiol (1998) 1.08
A reappraisal of papillary muscle dysfunction; correlative clinical and angiographic study. Am J Med (1969) 1.08
Effects of nitroglycerin on regional myocardial blood flow in coronary artery disease. J Clin Invest (1971) 1.08
Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine. The epinephrine ventriculogram. Circulation (1974) 1.08
Ventricular premature beats and anatomically defined coronary heart disease. Am J Cardiol (1977) 1.08
Regional myocardial blood flow. J Clin Invest (1967) 1.07
Isoproterenol in treatment of heart disease. Hemodynamic effects in circulatory failure. JAMA (1966) 1.07
Dynamic changes in left ventricular free wall thickness in the human heart. Circulation (1969) 1.07
Protecting the acutely ischemic myocardium beyond reperfusion therapies: are we any closer to realizing the dream of infarct size elimination? Arch Mal Coeur Vaiss (2007) 1.06
A comparison of transmural and nontransmural acute myocardial infarction. Circulation (1974) 1.06
Objective criteria for internal mammary artery implantation. Ann Thorac Surg (1967) 1.06
Effect of supine exercise on left ventricular volume and oxygen consumption in man. Circulation (1965) 1.06
Impaired coronary vasodilator responsiveness as a cause of lactate production during pacing-induced ischemia in patients with angina pectoris and normal coronary arteries. J Am Coll Cardiol (1987) 1.05
alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res (1994) 1.05
Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton. Am J Physiol (1999) 1.05
Infarct limitation of the second window of protection in a conscious rabbit model. Cardiovasc Res (1996) 1.04
Apparatus for study of ventricular function and metabolism in the isolated perfused rat heart. J Appl Physiol (1967) 1.03
Coronary steal: its role in detrimental effect of isoproterenol after acute coronary occlusion in dogs. Am J Cardiol (1976) 1.03
Premature coronary artery disease in identical male twins studied by selective coronary arteriography. Cathet Cardiovasc Diagn (1975) 1.03
Abnormalities of ventricular motion induced by atrial pacing in coronary artery disease. Circulation (1972) 1.03
Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. Circ Res (2000) 1.03
Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation (1993) 1.02
Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure. N Engl J Med (1982) 1.02